HippoScreen Neurotech Corp.

HippoScreen Neurotech Corp. is rated 3 out of 5 in the category health. Read and write reviews about HippoScreen Neurotech Corp.. HippoScreen Neurotech Corp. (HNC) is established to fill the gap in mental health diagnosis. Before company established, we worked with Psychiatrists to assess whether electroencephalogram (EEG) can be used for depression diagnosis, because they would like to seek for a biomarker which can provide objective and quantitative information as depression diagnosis aid. The results are inspiring, and we also have papers published. At that time, we realized it should not be the end, and we should step forward to make it productized, because there are too many people suffering from depression but not receiving any treatment due to inaccurate assessment. We believe that’s something we can help and that’s why HNC was established. With the highly integrated hardware and software, we wish to become WW #1 EEG-based mental healthcare solution provider. SEA system is the world's first product to diagnose depression with brainwaves. Unlike other diseases can be diagnosed by lab tests (e.g. blood test or X-ray), doctor can only follow guideline to ask questions about patients’ feelings, mood, sleeping habits, and other symptoms to diagnose depression. SEA system can analyze brainwaves and generate assessment report to help doctors provide more accurate diagnosis. It has three advantages as follows: 1) Fast measurement, it only takes 2 mins from capturing brainwaves to generate assessment report. 2) High usability, it only requires 8 channels of EEG data and thus the system setup is very simple. 3) High accuracy, the AI algorithm can achieve above 80% accuracy with clinical data evaluation. In the meantime, HNC is also developing the algorithms for EEG-based detection of Attention Deficit Hyperactivity Disorder (ADHD), Alzheimer's disease (AD), and the pre-stage of AD: Mild Cognitive Impairment (MCI).